ketanserin has been researched along with Altitude Sickness in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Altitude Sickness: Multiple symptoms associated with reduced oxygen at high ALTITUDE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Papamatheakis, DG | 1 |
Vemulakonda, S | 1 |
Blood, Q | 1 |
Goyal, R | 1 |
Rubalcava, M | 1 |
Vrancken, K | 1 |
Bennett, A | 1 |
Dawson, A | 1 |
Osman, NJ | 1 |
Blood, AB | 1 |
Pearce, WJ | 1 |
Longo, LD | 1 |
Wilson, SM | 1 |
1 other study available for ketanserin and Altitude Sickness
Article | Year |
---|---|
Preservation of serotonin-mediated contractility in adult sheep pulmonary arteries following long-term high-altitude hypoxia.
Topics: Altitude Sickness; Animals; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; | 2011 |